[
  {
    "numberVerification": [
      {
        "longNumber": 281474976710655
      }
    ]
  },
  {
    "metaData": [
      {
        "consistencyGroup": 1,
        "elementCount": 1,
        "lastUpdate": 1507763425988,
        "name": "ndexStatus",
        "properties": [],
        "version": "1.0"
      },
      {
        "consistencyGroup": 1,
        "elementCount": 1,
        "lastUpdate": 1507762851414,
        "name": "provenanceHistory",
        "properties": [],
        "version": "1.0"
      },
      {
        "name": "@context",
        "elementCount": 1,
        "version": "1.0",
        "consistencyGroup": 2,
        "properties": []
      },
      {
        "consistencyGroup": 1,
        "elementCount": 14,
        "idCounter": 135,
        "name": "nodes"
      },
      {
        "consistencyGroup": 1,
        "elementCount": 37,
        "idCounter": 135,
        "name": "edges"
      },
      {
        "consistencyGroup": 1,
        "elementCount": 46,
        "idCounter": 135,
        "name": "supports"
      },
      {
        "consistencyGroup": 1,
        "elementCount": 38,
        "idCounter": 135,
        "name": "citations"
      },
      {
        "consistencyGroup": 1,
        "elementCount": 296,
        "idCounter": 135,
        "name": "edgeAttributes"
      },
      {
        "consistencyGroup": 1,
        "elementCount": 37,
        "idCounter": 135,
        "name": "edgeCitations"
      },
      {
        "consistencyGroup": 1,
        "elementCount": 37,
        "idCounter": 135,
        "name": "edgeSupports"
      },
      {
        "consistencyGroup": 1,
        "elementCount": 7,
        "idCounter": 135,
        "name": "networkAttributes"
      },
      {
        "consistencyGroup": 1,
        "elementCount": 36,
        "idCounter": 135,
        "name": "nodeAttributes"
      }
    ]
  },
  {
    "ndexStatus": [
      {
        "externalId": "b7190ca4-aec2-11e7-9b0a-06832d634f41",
        "creationTime": 1507753697687,
        "modificationTime": 1507763425988,
        "visibility": "PRIVATE",
        "published": false,
        "nodeCount": 14,
        "edgeCount": 37,
        "owner": "scratch",
        "ndexServerURI": "http://dev.ndexbio.org",
        "readOnly": true
      }
    ]
  },
  {
    "provenanceHistory": [
      {
        "entity": {
          "uri": null,
          "creationEvent": null,
          "properties": []
        }
      }
    ]
  },
  {
    "@context": [
      {
        "pubmed": "http://identifiers.org/pubmed/",
        "cas": "http://identifiers.org/cas/",
        "chebi": "http://identifiers.org/chebi/CHEBI:",
        "hprd": "http://identifiers.org/hprd/",
        "uniprot knowledgebase": "http://identifiers.org/uniprot/",
        "KEGG Compound": "http://identifiers.org/kegg.compound/"
      }
    ]
  },
  {
    "nodes": [
      {
        "@id": 0,
        "n": "BRAF"
      },
      {
        "@id": 1,
        "n": "ERK"
      },
      {
        "@id": 5,
        "n": "MEK"
      },
      {
        "@id": 50,
        "n": "KRAS"
      },
      {
        "@id": 54,
        "n": "RAF1"
      },
      {
        "@id": 59,
        "n": "senescence"
      },
      {
        "@id": 63,
        "n": "EGFR"
      },
      {
        "@id": 71,
        "n": "MC1R"
      },
      {
        "@id": 81,
        "n": "RAF_inhibitors"
      },
      {
        "@id": 82,
        "n": "RAF"
      },
      {
        "@id": 86,
        "n": "vemurafenib"
      },
      {
        "@id": 101,
        "n": "Dabrafenib"
      },
      {
        "@id": 118,
        "n": "Trametinib"
      },
      {
        "@id": 131,
        "n": "KSR1"
      }
    ]
  },
  {
    "edges": [
      {
        "@id": 2,
        "s": 0,
        "t": 1,
        "i": "Activation"
      },
      {
        "@id": 6,
        "s": 0,
        "t": 5,
        "i": "Activation"
      },
      {
        "@id": 9,
        "s": 0,
        "t": 1,
        "i": "Activation"
      },
      {
        "@id": 12,
        "s": 0,
        "t": 5,
        "i": "Activation"
      },
      {
        "@id": 15,
        "s": 0,
        "t": 1,
        "i": "Activation"
      },
      {
        "@id": 18,
        "s": 0,
        "t": 5,
        "i": "Activation"
      },
      {
        "@id": 21,
        "s": 0,
        "t": 1,
        "i": "Activation"
      },
      {
        "@id": 24,
        "s": 0,
        "t": 5,
        "i": "Activation"
      },
      {
        "@id": 27,
        "s": 0,
        "t": 1,
        "i": "Activation"
      },
      {
        "@id": 30,
        "s": 0,
        "t": 5,
        "i": "Activation"
      },
      {
        "@id": 33,
        "s": 0,
        "t": 1,
        "i": "Activation"
      },
      {
        "@id": 37,
        "s": 0,
        "t": 5,
        "i": "Activation"
      },
      {
        "@id": 40,
        "s": 0,
        "t": 1,
        "i": "Activation"
      },
      {
        "@id": 43,
        "s": 0,
        "t": 5,
        "i": "Activation"
      },
      {
        "@id": 46,
        "s": 0,
        "t": 1,
        "i": "Activation"
      },
      {
        "@id": 51,
        "s": 0,
        "t": 50,
        "i": "Activation"
      },
      {
        "@id": 55,
        "s": 0,
        "t": 54,
        "i": "Activation"
      },
      {
        "@id": 60,
        "s": 0,
        "t": 59,
        "i": "Activation"
      },
      {
        "@id": 64,
        "s": 63,
        "t": 0,
        "i": "Activation"
      },
      {
        "@id": 67,
        "s": 1,
        "t": 54,
        "i": "Activation"
      },
      {
        "@id": 72,
        "s": 71,
        "t": 0,
        "i": "Activation"
      },
      {
        "@id": 75,
        "s": 54,
        "t": 1,
        "i": "Activation"
      },
      {
        "@id": 83,
        "s": 81,
        "t": 82,
        "i": "Activation"
      },
      {
        "@id": 87,
        "s": 86,
        "t": 0,
        "i": "Activation"
      },
      {
        "@id": 90,
        "s": 54,
        "t": 0,
        "i": "Complex"
      },
      {
        "@id": 93,
        "s": 0,
        "t": 1,
        "i": "Inhibition"
      },
      {
        "@id": 98,
        "s": 0,
        "t": 5,
        "i": "Inhibition"
      },
      {
        "@id": 102,
        "s": 101,
        "t": 0,
        "i": "Inhibition"
      },
      {
        "@id": 105,
        "s": 101,
        "t": 54,
        "i": "Inhibition"
      },
      {
        "@id": 108,
        "s": 54,
        "t": 1,
        "i": "Inhibition"
      },
      {
        "@id": 112,
        "s": 54,
        "t": 5,
        "i": "Inhibition"
      },
      {
        "@id": 115,
        "s": 54,
        "t": 81,
        "i": "Inhibition"
      },
      {
        "@id": 119,
        "s": 118,
        "t": 0,
        "i": "Inhibition"
      },
      {
        "@id": 122,
        "s": 0,
        "t": 1,
        "i": "Phosphorylation"
      },
      {
        "@id": 125,
        "s": 0,
        "t": 5,
        "i": "Phosphorylation"
      },
      {
        "@id": 128,
        "s": 101,
        "t": 54,
        "i": "Phosphorylation"
      },
      {
        "@id": 132,
        "s": 131,
        "t": 82,
        "i": "Phosphorylation"
      }
    ]
  },
  {
    "supports": [
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 4,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 8,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 11,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 14,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 17,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 20,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 23,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 26,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 29,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 32,
        "attributes": []
      },
      {
        "text": "As we observed, D594V BRAF, even in the presence of CRAF, did not induce strong ERK activity.",
        "citation": null,
        "@id": 35,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 36,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 39,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 42,
        "attributes": []
      },
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.",
        "citation": null,
        "@id": 45,
        "attributes": []
      },
      {
        "text": "The BRAF V600E mutation activates MAPK, affecting cell proliferation, differentiation, and survival.",
        "citation": null,
        "@id": 48,
        "attributes": []
      },
      {
        "text": "BRAF V600E mutation has been reported to abnormally activate MAPK signal pathway.",
        "citation": null,
        "@id": 49,
        "attributes": []
      },
      {
        "text": "This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.",
        "citation": null,
        "@id": 53,
        "attributes": []
      },
      {
        "text": "A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.",
        "citation": null,
        "@id": 57,
        "attributes": []
      },
      {
        "text": "This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.",
        "citation": null,
        "@id": 58,
        "attributes": []
      },
      {
        "text": "Some studies also found that constitutive BRAF activity induces MAPK activity and glioma genesis in xenografted mice but eventually leads to tumour senescence.",
        "citation": null,
        "@id": 62,
        "attributes": []
      },
      {
        "text": "Retraction : EGFR Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines.",
        "citation": null,
        "@id": 66,
        "attributes": []
      },
      {
        "text": "A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.",
        "citation": null,
        "@id": 69,
        "attributes": []
      },
      {
        "text": "In addition, combined Dabrafenib and Trametinib treatment inhibited Dabrafenib induced ERK activation in CRAF overexpressing monotransfectants.",
        "citation": null,
        "@id": 70,
        "attributes": []
      },
      {
        "text": "Palmitoylation deficient MC1R variants accelerate BRAF (V60E)-driven melanomagenesis.",
        "citation": null,
        "@id": 74,
        "attributes": []
      },
      {
        "text": "In HEK293T cells, Trametinib modestly decreased ERK activity induced by BRAF mutations conferring elevated kinase activity while strongly inhibited kinase impaired BRAF and CRAF induced ERK activation.",
        "citation": null,
        "@id": 78,
        "attributes": []
      },
      {
        "text": "A recent study revealed the superior efficacy of Trametinib versus several other MEK-inhibitors in cells with KRAS mutations and CRAF mediated ERK pathway activation [].",
        "citation": null,
        "@id": 79,
        "attributes": []
      },
      {
        "text": "In BRAFi resistant cells, PAKs phosphorylate CRAF and MEK to reactivate ERK.",
        "citation": null,
        "@id": 80,
        "attributes": []
      },
      {
        "text": "Currently approved RAF inhibitors inhibit RAF monomers but not dimers.",
        "citation": null,
        "@id": 85,
        "attributes": []
      },
      {
        "text": "From November 2012 to October 2015 we have selected 43 BRAF mutated, metastatic melanoma patients, treated with vemurafenib.",
        "citation": null,
        "@id": 89,
        "attributes": []
      },
      {
        "text": "However, kinase impairing BRAF mutations still induce ERK pathway activation when wild-type CRAF, a hetero-dimerization partner of BRAF, is also present in the cell [].",
        "citation": null,
        "@id": 92,
        "attributes": []
      },
      {
        "text": "As previously reported, kinase impaired BRAF mutants can still activate the ERK pathway in a CRAF dependent manner [].",
        "citation": null,
        "@id": 95,
        "attributes": []
      },
      {
        "text": "Inhibitory effect of Dabrafenib on mutant BRAF induced ERK signaling.",
        "citation": null,
        "@id": 96,
        "attributes": []
      },
      {
        "text": "Inhibitory effect of Trametinib on mutant BRAF induced ERK signaling.",
        "citation": null,
        "@id": 97,
        "attributes": []
      },
      {
        "text": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.",
        "citation": null,
        "@id": 100,
        "attributes": []
      },
      {
        "text": "Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.",
        "citation": null,
        "@id": 104,
        "attributes": []
      },
      {
        "text": "The IC50 of Dabrafenib to inhibit CRAF is ~ 10-fold less than that of Vemurafenib [ - ].",
        "citation": null,
        "@id": 107,
        "attributes": []
      },
      {
        "text": "The study reveals that two MEK inhibitors (Selumetinib and PD0325901) are less efficient than Trametinib for sustained suppression of CRAF mediated ERK activity.",
        "citation": null,
        "@id": 110,
        "attributes": []
      },
      {
        "text": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.",
        "citation": null,
        "@id": 111,
        "attributes": []
      },
      {
        "text": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.",
        "citation": null,
        "@id": 114,
        "attributes": []
      },
      {
        "text": "Therefore, it has yet to be determined whether over time activated CRAF can contribute to kinase independent resistance mechanisms to RAF inhibitors in BRAF mutated cancers [].",
        "citation": null,
        "@id": 117,
        "attributes": []
      },
      {
        "text": "Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.",
        "citation": null,
        "@id": 121,
        "attributes": []
      },
      {
        "text": "Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.",
        "citation": null,
        "@id": 124,
        "attributes": []
      },
      {
        "text": "Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.",
        "citation": null,
        "@id": 127,
        "attributes": []
      },
      {
        "text": "We observed that Dabrafenib treatment of all HEK293T transfectants resulted in phosphorylation of the transfected CRAF molecule at S338, irrespective of the presence and type of BRAF molecule.",
        "citation": null,
        "@id": 130,
        "attributes": []
      },
      {
        "text": "Of the five up-regulated genes, P21 and P19 encode for inhibitors for the cyclin D and the CDK4/6 complex; CFOS and CJUN are down stream of ERK and JNK kinases, and KSR1 promotes MEK and RAF phosphorylation.",
        "citation": null,
        "@id": 134,
        "attributes": []
      }
    ]
  },
  {
    "citations": [
      {
        "@id": 3,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 7,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 10,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 13,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 16,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 19,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 22,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 25,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 28,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 31,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 34,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 38,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 41,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 44,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 47,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28986151",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 52,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 56,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 61,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28986151",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 65,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28974625",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 68,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 73,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28916587",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 76,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 77,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28953887",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 84,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28951457",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 88,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28963614",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 91,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 94,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 99,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 103,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 106,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 109,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 113,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 116,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 120,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 123,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 126,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 129,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28947956",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      },
      {
        "@id": 133,
        "dc:title": null,
        "dc:contributor": null,
        "dc:identifier": "pmid:28959611",
        "dc:type": null,
        "dc:description": null,
        "attributes": []
      }
    ]
  },
  {
    "edgeAttributes": [
      {
        "po": 2,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (G, 466, V)), ERK())"
      },
      {
        "po": 2,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"466\", \"residue_from\": \"G\", \"residue_to\": \"V\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"6bf35494-4c76-43f2-bfe8-ff9ab1649876\", \"supported_by\": [\"68e0c377-cf08-4f78-ac3a-c091adb87f1f\", \"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"801a10a6-8690-4c82-814e-2e107613971d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 2,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 2,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 2,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 2,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 2,
        "n": "indra",
        "v": ""
      },
      {
        "po": 2,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 6,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (G, 466, V)), MEK())"
      },
      {
        "po": 6,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"466\", \"residue_from\": \"G\", \"residue_to\": \"V\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"d0fc25e0-ec0d-4864-a6fb-b5a27069da65\", \"supported_by\": [\"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\", \"771097ad-717f-41da-b345-69c33dff8de4\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 6,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 6,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 6,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 6,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 6,
        "n": "indra",
        "v": ""
      },
      {
        "po": 6,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 9,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (D, 594, A)), ERK())"
      },
      {
        "po": 9,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"A\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"c08e01a8-1106-44cc-b3ed-faac092033fc\", \"supported_by\": [\"68e0c377-cf08-4f78-ac3a-c091adb87f1f\", \"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"801a10a6-8690-4c82-814e-2e107613971d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 9,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 9,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 9,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 9,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 9,
        "n": "indra",
        "v": ""
      },
      {
        "po": 9,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 12,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (D, 594, A)), MEK())"
      },
      {
        "po": 12,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"A\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"e3b4735f-b0dd-4a4a-a732-deb4c716b6a7\", \"supported_by\": [\"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\", \"771097ad-717f-41da-b345-69c33dff8de4\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 12,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 12,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 12,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 12,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 12,
        "n": "indra",
        "v": ""
      },
      {
        "po": 12,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 15,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (D, 594, E)), ERK())"
      },
      {
        "po": 15,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"E\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"43958f7b-e4f0-4c26-9072-37e6646b7d1c\", \"supported_by\": [\"801a10a6-8690-4c82-814e-2e107613971d\", \"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"68e0c377-cf08-4f78-ac3a-c091adb87f1f\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 15,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 15,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 15,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 15,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 15,
        "n": "indra",
        "v": ""
      },
      {
        "po": 15,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 18,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (D, 594, E)), MEK())"
      },
      {
        "po": 18,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"E\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"3af54d2c-a4c4-41e2-b126-cb16b03f908a\", \"supported_by\": [\"771097ad-717f-41da-b345-69c33dff8de4\", \"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 18,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 18,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 18,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 18,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 18,
        "n": "indra",
        "v": ""
      },
      {
        "po": 18,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 21,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (D, 594, G)), ERK())"
      },
      {
        "po": 21,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"G\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"64a1f4a8-8d7d-4d28-b417-8abb818c33e2\", \"supported_by\": [\"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"68e0c377-cf08-4f78-ac3a-c091adb87f1f\", \"801a10a6-8690-4c82-814e-2e107613971d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 21,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 21,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 21,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 21,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 21,
        "n": "indra",
        "v": ""
      },
      {
        "po": 21,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 24,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (D, 594, G)), MEK())"
      },
      {
        "po": 24,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"G\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"e1abe305-32b4-4a32-ad2b-08c7fc78cb5a\", \"supported_by\": [\"771097ad-717f-41da-b345-69c33dff8de4\", \"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 24,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 24,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 24,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 24,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 24,
        "n": "indra",
        "v": ""
      },
      {
        "po": 24,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 27,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (D, 594, N)), ERK())"
      },
      {
        "po": 27,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"N\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"98d42160-3c9c-4cd8-89da-8bcebb7caae3\", \"supported_by\": [\"68e0c377-cf08-4f78-ac3a-c091adb87f1f\", \"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"801a10a6-8690-4c82-814e-2e107613971d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 27,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 27,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 27,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 27,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 27,
        "n": "indra",
        "v": ""
      },
      {
        "po": 27,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 30,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (D, 594, N)), MEK())"
      },
      {
        "po": 30,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"N\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"f3a51c3f-75fd-486d-8563-d1db91eb39fe\", \"supported_by\": [\"771097ad-717f-41da-b345-69c33dff8de4\", \"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 30,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 30,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 30,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 30,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 30,
        "n": "indra",
        "v": ""
      },
      {
        "po": 30,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 33,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (D, 594, V)), ERK())"
      },
      {
        "po": 33,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"V\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"As we observed, D594V BRAF, even in the presence of CRAF, did not induce strong ERK activity.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"00a6e12c-eba7-498b-a59c-a27a21a91d85\", \"supported_by\": [\"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"801a10a6-8690-4c82-814e-2e107613971d\", \"68e0c377-cf08-4f78-ac3a-c091adb87f1f\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 33,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 33,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 33,
        "n": "Belief score",
        "v": "0.86"
      },
      {
        "po": 33,
        "n": "Text",
        "v": "As we observed, D594V BRAF, even in the presence of CRAF, did not induce strong ERK activity."
      },
      {
        "po": 33,
        "n": "indra",
        "v": ""
      },
      {
        "po": 33,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 37,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (D, 594, V)), MEK())"
      },
      {
        "po": 37,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"V\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"581301ea-cbaf-4c59-9d5a-9405a743962f\", \"supported_by\": [\"771097ad-717f-41da-b345-69c33dff8de4\", \"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 37,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 37,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 37,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 37,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 37,
        "n": "indra",
        "v": ""
      },
      {
        "po": 37,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 40,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (G, 596, C)), ERK())"
      },
      {
        "po": 40,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"596\", \"residue_from\": \"G\", \"residue_to\": \"C\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"3492dad4-9228-4e61-ad08-28c2c8ababb3\", \"supported_by\": [\"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"801a10a6-8690-4c82-814e-2e107613971d\", \"68e0c377-cf08-4f78-ac3a-c091adb87f1f\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 40,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 40,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 40,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 40,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 40,
        "n": "indra",
        "v": ""
      },
      {
        "po": 40,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 43,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (G, 596, C)), MEK())"
      },
      {
        "po": 43,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"596\", \"residue_from\": \"G\", \"residue_to\": \"C\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"a714426b-948a-436a-9bdb-47c007f8bc8e\", \"supported_by\": [\"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\", \"771097ad-717f-41da-b345-69c33dff8de4\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 43,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 43,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 43,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 43,
        "n": "Text",
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF."
      },
      {
        "po": 43,
        "n": "indra",
        "v": ""
      },
      {
        "po": 43,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 46,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (V, 600, E)), ERK())"
      },
      {
        "po": 46,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"600\", \"residue_from\": \"V\", \"residue_to\": \"E\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"MAPK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28986151\", \"text\": \"The BRAF V600E mutation activates MAPK, affecting cell proliferation, differentiation, and survival.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28986151\", \"text\": \"BRAF V600E mutation has been reported to abnormally activate MAPK signal pathway.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"6cb10cca-7d40-48b6-ba4e-12766a7d4029\", \"supported_by\": [\"68e0c377-cf08-4f78-ac3a-c091adb87f1f\", \"801a10a6-8690-4c82-814e-2e107613971d\", \"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 46,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 46,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 46,
        "n": "Belief score",
        "v": "0.86"
      },
      {
        "po": 46,
        "n": "Text",
        "v": "The BRAF V600E mutation activates MAPK, affecting cell proliferation, differentiation, and survival."
      },
      {
        "po": 46,
        "n": "indra",
        "v": ""
      },
      {
        "po": 46,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 51,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (None, None, None)), KRAS())"
      },
      {
        "po": 51,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": null, \"residue_from\": null, \"residue_to\": null}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"KRAS\", \"db_refs\": {\"TEXT\": \"KRAS\", \"UP\": \"P01116\", \"HGNC\": \"6407\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_7_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"5a1dfdf7-5f79-4a9c-a753-37c2ec76b177\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 51,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 51,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 51,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 51,
        "n": "Text",
        "v": "This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells."
      },
      {
        "po": 51,
        "n": "indra",
        "v": ""
      },
      {
        "po": 51,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 55,
        "n": "INDRA statement",
        "v": "Activation(BRAF(muts: (None, None, None)), RAF1())"
      },
      {
        "po": 55,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": null, \"residue_from\": null, \"residue_to\": null}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"389a79fd-59a9-4948-b8e4-c98a525b11fc\", \"supported_by\": [\"b939dd60-2425-4db4-8d27-88782444892e\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 55,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 55,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 55,
        "n": "Belief score",
        "v": "0.86"
      },
      {
        "po": 55,
        "n": "Text",
        "v": "A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF."
      },
      {
        "po": 55,
        "n": "indra",
        "v": ""
      },
      {
        "po": 55,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 60,
        "n": "INDRA statement",
        "v": "Activation(BRAF(), senescence())"
      },
      {
        "po": 60,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"senescence\", \"db_refs\": {\"GO\": \"GO:0090398\", \"TEXT\": \"senescence\", \"MESH\": \"D016922\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28986151\", \"text\": \"Some studies also found that constitutive BRAF activity induces MAPK activity and glioma genesis in xenografted mice but eventually leads to tumour senescence.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_7_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"dc7fb5b6-1ac9-4a2c-ba35-17627337fdf8\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 60,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 60,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 60,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 60,
        "n": "Text",
        "v": "Some studies also found that constitutive BRAF activity induces MAPK activity and glioma genesis in xenografted mice but eventually leads to tumour senescence."
      },
      {
        "po": 60,
        "n": "indra",
        "v": ""
      },
      {
        "po": 60,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 64,
        "n": "INDRA statement",
        "v": "Activation(EGFR(), BRAF())"
      },
      {
        "po": 64,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"EGFR\", \"db_refs\": {\"TEXT\": \"EGFR\", \"UP\": \"P00533\", \"HGNC\": \"3236\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28974625\", \"text\": \"Retraction : EGFR Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"b202c476-e5de-44a5-bacc-599a21695a36\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 64,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 64,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 64,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 64,
        "n": "Text",
        "v": "Retraction : EGFR Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines."
      },
      {
        "po": 64,
        "n": "indra",
        "v": ""
      },
      {
        "po": 64,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 67,
        "n": "INDRA statement",
        "v": "Activation(ERK(), RAF1())"
      },
      {
        "po": 67,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"In addition, combined Dabrafenib and Trametinib treatment inhibited Dabrafenib induced ERK activation in CRAF overexpressing monotransfectants.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_3_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"c56399b1-5c85-406c-8609-f68b731adecd\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 67,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 67,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 67,
        "n": "Belief score",
        "v": "0.86"
      },
      {
        "po": 67,
        "n": "Text",
        "v": "A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF."
      },
      {
        "po": 67,
        "n": "indra",
        "v": ""
      },
      {
        "po": 67,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 72,
        "n": "INDRA statement",
        "v": "Activation(MC1R(), BRAF())"
      },
      {
        "po": 72,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"MC1R\", \"db_refs\": {\"TEXT\": \"MC1R\", \"UP\": \"Q01726\", \"HGNC\": \"6929\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28916587\", \"text\": \"Palmitoylation deficient MC1R variants accelerate BRAF (V60E)-driven melanomagenesis.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"2fc7fda0-15b0-414e-8ff7-025f45cb8c0b\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 72,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 72,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 72,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 72,
        "n": "Text",
        "v": "Palmitoylation deficient MC1R variants accelerate BRAF (V60E)-driven melanomagenesis."
      },
      {
        "po": 72,
        "n": "indra",
        "v": ""
      },
      {
        "po": 72,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 75,
        "n": "INDRA statement",
        "v": "Activation(RAF1(), ERK())"
      },
      {
        "po": 75,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"In HEK293T cells, Trametinib modestly decreased ERK activity induced by BRAF mutations conferring elevated kinase activity while strongly inhibited kinase impaired BRAF and CRAF induced ERK activation.\", \"annotations\": {\"found_by\": \"Positive_early_activation\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"A recent study revealed the superior efficacy of Trametinib versus several other MEK-inhibitors in cells with KRAS mutations and CRAF mediated ERK pathway activation [XREF_BIBR].\", \"annotations\": {\"found_by\": \"Positive_early_activation\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28953887\", \"text\": \"In BRAFi resistant cells, PAKs phosphorylate CRAF and MEK to reactivate ERK.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"65ffaa64-8419-4f74-818a-d43992319f17\", \"supported_by\": [\"801a10a6-8690-4c82-814e-2e107613971d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 75,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 75,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 75,
        "n": "Belief score",
        "v": "0.92"
      },
      {
        "po": 75,
        "n": "Text",
        "v": "In HEK293T cells, Trametinib modestly decreased ERK activity induced by BRAF mutations conferring elevated kinase activity while strongly inhibited kinase impaired BRAF and CRAF induced ERK activation."
      },
      {
        "po": 75,
        "n": "indra",
        "v": ""
      },
      {
        "po": 75,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 83,
        "n": "INDRA statement",
        "v": "Activation(RAF_inhibitors(), RAF())"
      },
      {
        "po": 83,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"RAF_inhibitors\", \"db_refs\": {\"TEXT\": \"RAF inhibitors\", \"CHEBI\": \"CHEBI:75047\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"RAF\", \"db_refs\": {\"TEXT\": \"RAF\", \"BE\": \"RAF\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28951457\", \"text\": \"Currently approved RAF inhibitors inhibit RAF monomers but not dimers.\", \"annotations\": {\"found_by\": \"Negative_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"5ba5fe59-5973-48f3-871c-dbf2e2108436\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 83,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 83,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 83,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 83,
        "n": "Text",
        "v": "Currently approved RAF inhibitors inhibit RAF monomers but not dimers."
      },
      {
        "po": 83,
        "n": "indra",
        "v": ""
      },
      {
        "po": 83,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 87,
        "n": "INDRA statement",
        "v": "Activation(vemurafenib(), BRAF())"
      },
      {
        "po": 87,
        "n": "INDRA json",
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"vemurafenib\", \"db_refs\": {\"TEXT\": \"vemurafenib\", \"CHEBI\": \"CHEBI:63637\", \"PUBCHEM\": \"42611257\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28963614\", \"text\": \"From November 2012 to October 2015 we have selected 43 BRAF mutated, metastatic melanoma patients, treated with vemurafenib.\", \"annotations\": {\"found_by\": \"Positive_activation_surface_treated_with\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"2157d53e-94d4-424c-99eb-754e1beb7a6d\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 87,
        "n": "type",
        "v": "Activation"
      },
      {
        "po": 87,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 87,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 87,
        "n": "Text",
        "v": "From November 2012 to October 2015 we have selected 43 BRAF mutated, metastatic melanoma patients, treated with vemurafenib."
      },
      {
        "po": 87,
        "n": "indra",
        "v": ""
      },
      {
        "po": 87,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 90,
        "n": "INDRA statement",
        "v": "Complex(RAF1(), BRAF())"
      },
      {
        "po": 90,
        "n": "INDRA json",
        "v": "{\"type\": \"Complex\", \"members\": [{\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}}, {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}}], \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"However, kinase impairing BRAF mutations still induce ERK pathway activation when wild-type CRAF, a hetero-dimerization partner of BRAF, is also present in the cell [XREF_BIBR].\", \"annotations\": {\"cell_type\": null, \"organ\": null, \"found_by\": \"binding_19\", \"tissue\": null, \"location\": null, \"cell_line\": null, \"species\": [\"taxonomy:9606\"]}, \"epistemics\": {\"section_type\": null, \"direct\": true}}], \"id\": \"aa33b60b-1dfd-43c7-8fd4-e0af85bdf988\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000526\"}"
      },
      {
        "po": 90,
        "n": "type",
        "v": "Complex"
      },
      {
        "po": 90,
        "n": "polarity",
        "v": "none"
      },
      {
        "po": 90,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 90,
        "n": "Text",
        "v": "However, kinase impairing BRAF mutations still induce ERK pathway activation when wild-type CRAF, a hetero-dimerization partner of BRAF, is also present in the cell [XREF_BIBR]."
      },
      {
        "po": 90,
        "n": "indra",
        "v": ""
      },
      {
        "po": 90,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 93,
        "n": "INDRA statement",
        "v": "Inhibition(BRAF(muts: (None, None, None)), ERK())"
      },
      {
        "po": 93,
        "n": "INDRA json",
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": null, \"residue_from\": null, \"residue_to\": null}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"As previously reported, kinase impaired BRAF mutants can still activate the ERK pathway in a CRAF dependent manner [XREF_BIBR].\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Inhibitory effect of Dabrafenib on mutant BRAF induced ERK signaling.\", \"annotations\": {\"found_by\": \"Positive_early_activation\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Inhibitory effect of Trametinib on mutant BRAF induced ERK signaling.\", \"annotations\": {\"found_by\": \"Positive_early_activation\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"7b9004b3-1185-42aa-b3bc-cb6376afeed6\", \"supported_by\": [\"8801cc23-52d0-47aa-9f50-90150a675b3d\", \"25cc8002-0c51-42cf-ad7b-4a2b0cd922da\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 93,
        "n": "type",
        "v": "Inhibition"
      },
      {
        "po": 93,
        "n": "polarity",
        "v": "negative"
      },
      {
        "po": 93,
        "n": "Belief score",
        "v": "0.92"
      },
      {
        "po": 93,
        "n": "Text",
        "v": "As previously reported, kinase impaired BRAF mutants can still activate the ERK pathway in a CRAF dependent manner [XREF_BIBR]."
      },
      {
        "po": 93,
        "n": "indra",
        "v": ""
      },
      {
        "po": 93,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 98,
        "n": "INDRA statement",
        "v": "Inhibition(BRAF(), MEK())"
      },
      {
        "po": 98,
        "n": "INDRA json",
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"32b9b643-213e-45f3-b979-f3fc5c82fcde\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 98,
        "n": "type",
        "v": "Inhibition"
      },
      {
        "po": 98,
        "n": "polarity",
        "v": "negative"
      },
      {
        "po": 98,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 98,
        "n": "Text",
        "v": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells."
      },
      {
        "po": 98,
        "n": "indra",
        "v": ""
      },
      {
        "po": 98,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 102,
        "n": "INDRA statement",
        "v": "Inhibition(Dabrafenib(), BRAF())"
      },
      {
        "po": 102,
        "n": "INDRA json",
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"Dabrafenib\", \"db_refs\": {\"PUBCHEM\": \"44462760\", \"TEXT\": \"Dabrafenib\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"39d890f3-31eb-4d3d-a2ca-4042415f5a38\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 102,
        "n": "type",
        "v": "Inhibition"
      },
      {
        "po": 102,
        "n": "polarity",
        "v": "negative"
      },
      {
        "po": 102,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 102,
        "n": "Text",
        "v": "Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines."
      },
      {
        "po": 102,
        "n": "indra",
        "v": ""
      },
      {
        "po": 102,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 105,
        "n": "INDRA statement",
        "v": "Inhibition(Dabrafenib(), RAF1())"
      },
      {
        "po": 105,
        "n": "INDRA json",
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"Dabrafenib\", \"db_refs\": {\"PUBCHEM\": \"44462760\", \"TEXT\": \"Dabrafenib\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The IC50 of Dabrafenib to inhibit CRAF is ~ 10-fold less than that of Vemurafenib [XREF_BIBR - XREF_BIBR].\", \"annotations\": {\"found_by\": \"Negative_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"6eb20af6-42c9-4209-9bb3-681d8716ba18\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 105,
        "n": "type",
        "v": "Inhibition"
      },
      {
        "po": 105,
        "n": "polarity",
        "v": "negative"
      },
      {
        "po": 105,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 105,
        "n": "Text",
        "v": "The IC50 of Dabrafenib to inhibit CRAF is ~ 10-fold less than that of Vemurafenib [XREF_BIBR - XREF_BIBR]."
      },
      {
        "po": 105,
        "n": "indra",
        "v": ""
      },
      {
        "po": 105,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 108,
        "n": "INDRA statement",
        "v": "Inhibition(RAF1(), ERK())"
      },
      {
        "po": 108,
        "n": "INDRA json",
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The study reveals that two MEK inhibitors (Selumetinib and PD0325901) are less efficient than Trametinib for sustained suppression of CRAF mediated ERK activity.\", \"annotations\": {\"found_by\": \"Positive_early_activation\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"6c1d5376-3224-4bd5-96ad-ecedd7d1c54c\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 108,
        "n": "type",
        "v": "Inhibition"
      },
      {
        "po": 108,
        "n": "polarity",
        "v": "negative"
      },
      {
        "po": 108,
        "n": "Belief score",
        "v": "0.86"
      },
      {
        "po": 108,
        "n": "Text",
        "v": "The study reveals that two MEK inhibitors (Selumetinib and PD0325901) are less efficient than Trametinib for sustained suppression of CRAF mediated ERK activity."
      },
      {
        "po": 108,
        "n": "indra",
        "v": ""
      },
      {
        "po": 108,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 112,
        "n": "INDRA statement",
        "v": "Inhibition(RAF1(), MEK())"
      },
      {
        "po": 112,
        "n": "INDRA json",
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"0db1c1bb-c7ab-47d2-a7ee-2ccb763f29d5\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 112,
        "n": "type",
        "v": "Inhibition"
      },
      {
        "po": 112,
        "n": "polarity",
        "v": "negative"
      },
      {
        "po": 112,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 112,
        "n": "Text",
        "v": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells."
      },
      {
        "po": 112,
        "n": "indra",
        "v": ""
      },
      {
        "po": 112,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 115,
        "n": "INDRA statement",
        "v": "Inhibition(RAF1(), RAF_inhibitors())"
      },
      {
        "po": 115,
        "n": "INDRA json",
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"RAF_inhibitors\", \"db_refs\": {\"TEXT\": \"RAF inhibitors\", \"CHEBI\": \"CHEBI:75047\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Therefore, it has yet to be determined whether over time activated CRAF can contribute to kinase independent resistance mechanisms to RAF inhibitors in BRAF mutated cancers [XREF_BIBR].\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_7_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"a9427ab8-7862-47ac-80ec-4e99bafb098a\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 115,
        "n": "type",
        "v": "Inhibition"
      },
      {
        "po": 115,
        "n": "polarity",
        "v": "negative"
      },
      {
        "po": 115,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 115,
        "n": "Text",
        "v": "Therefore, it has yet to be determined whether over time activated CRAF can contribute to kinase independent resistance mechanisms to RAF inhibitors in BRAF mutated cancers [XREF_BIBR]."
      },
      {
        "po": 115,
        "n": "indra",
        "v": ""
      },
      {
        "po": 115,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 119,
        "n": "INDRA statement",
        "v": "Inhibition(Trametinib(), BRAF())"
      },
      {
        "po": 119,
        "n": "INDRA json",
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"Trametinib\", \"db_refs\": {\"PUBCHEM\": \"11707110\", \"TEXT\": \"Trametinib\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"62edbe1c-da19-4fc2-9ce2-4eef86fe1025\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}"
      },
      {
        "po": 119,
        "n": "type",
        "v": "Inhibition"
      },
      {
        "po": 119,
        "n": "polarity",
        "v": "negative"
      },
      {
        "po": 119,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 119,
        "n": "Text",
        "v": "Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines."
      },
      {
        "po": 119,
        "n": "indra",
        "v": ""
      },
      {
        "po": 119,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 122,
        "n": "INDRA statement",
        "v": "Phosphorylation(BRAF(mods: (modification), muts: (None, None, None)), ERK())"
      },
      {
        "po": 122,
        "n": "INDRA json",
        "v": "{\"type\": \"Phosphorylation\", \"enz\": {\"name\": \"BRAF\", \"mods\": [{\"mod_type\": \"modification\", \"is_modified\": true}], \"mutations\": [{\"position\": null, \"residue_from\": null, \"residue_to\": null}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000460\"}, \"sub\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000015\"}, \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.\", \"annotations\": {\"cell_type\": null, \"organ\": null, \"found_by\": \"Phosphorylation_syntax_4_noun\", \"tissue\": null, \"location\": null, \"cell_line\": [\"cellosaurus:CVCL_0045\"], \"species\": [\"taxonomy:9606\"]}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"3c8c9c9f-91e7-419f-8738-b9529e7570b7\", \"supported_by\": [\"253bfc59-b6d9-4de2-9497-c1a219083bcb\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000216\"}"
      },
      {
        "po": 122,
        "n": "type",
        "v": "Modification"
      },
      {
        "po": 122,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 122,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 122,
        "n": "Text",
        "v": "Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation."
      },
      {
        "po": 122,
        "n": "indra",
        "v": ""
      },
      {
        "po": 122,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 125,
        "n": "INDRA statement",
        "v": "Phosphorylation(BRAF(mods: (modification), muts: (None, None, None)), MEK())"
      },
      {
        "po": 125,
        "n": "INDRA json",
        "v": "{\"type\": \"Phosphorylation\", \"enz\": {\"name\": \"BRAF\", \"mods\": [{\"mod_type\": \"modification\", \"is_modified\": true}], \"mutations\": [{\"position\": null, \"residue_from\": null, \"residue_to\": null}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000460\"}, \"sub\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000015\"}, \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.\", \"annotations\": {\"cell_type\": null, \"organ\": null, \"found_by\": \"Phosphorylation_syntax_4_noun\", \"tissue\": null, \"location\": null, \"cell_line\": [\"cellosaurus:CVCL_0045\"], \"species\": [\"taxonomy:9606\"]}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"96bc8290-e868-43f0-9ba1-1d6238924245\", \"supported_by\": [\"d298a9d6-568f-4abb-84da-1b2060a0b327\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000216\"}"
      },
      {
        "po": 125,
        "n": "type",
        "v": "Modification"
      },
      {
        "po": 125,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 125,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 125,
        "n": "Text",
        "v": "Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation."
      },
      {
        "po": 125,
        "n": "indra",
        "v": ""
      },
      {
        "po": 125,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 128,
        "n": "INDRA statement",
        "v": "Phosphorylation(Dabrafenib(), RAF1(), S, 338)"
      },
      {
        "po": 128,
        "n": "INDRA json",
        "v": "{\"type\": \"Phosphorylation\", \"enz\": {\"name\": \"Dabrafenib\", \"db_refs\": {\"PUBCHEM\": \"44462760\", \"TEXT\": \"Dabrafenib\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000460\"}, \"sub\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000015\"}, \"residue\": \"S\", \"position\": \"338\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"We observed that Dabrafenib treatment of all HEK293T transfectants resulted in phosphorylation of the transfected CRAF molecule at S338, irrespective of the presence and type of BRAF molecule.\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_1a_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"b7b02426-f9dd-4dd8-b623-52315acdcf48\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000216\"}"
      },
      {
        "po": 128,
        "n": "type",
        "v": "Modification"
      },
      {
        "po": 128,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 128,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 128,
        "n": "Text",
        "v": "We observed that Dabrafenib treatment of all HEK293T transfectants resulted in phosphorylation of the transfected CRAF molecule at S338, irrespective of the presence and type of BRAF molecule."
      },
      {
        "po": 128,
        "n": "indra",
        "v": ""
      },
      {
        "po": 128,
        "n": "supportType",
        "v": "literature"
      },
      {
        "po": 132,
        "n": "INDRA statement",
        "v": "Phosphorylation(KSR1(), RAF())"
      },
      {
        "po": 132,
        "n": "INDRA json",
        "v": "{\"type\": \"Phosphorylation\", \"enz\": {\"name\": \"KSR1\", \"db_refs\": {\"TEXT\": \"KSR1\", \"UP\": \"Q8IVT5\", \"HGNC\": \"6465\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000460\"}, \"sub\": {\"name\": \"RAF\", \"db_refs\": {\"TEXT\": \"RAF\", \"BE\": \"RAF\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000015\"}, \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28959611\", \"text\": \"Of the five up-regulated genes, P21 and P19 encode for inhibitors for the cyclin D and the CDK4/6 complex; CFOS and CJUN are down stream of ERK and JNK kinases, and KSR1 promotes MEK and RAF phosphorylation.\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_4_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"d475a8bc-a2eb-4898-a6d4-34a412323171\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000216\"}"
      },
      {
        "po": 132,
        "n": "type",
        "v": "Modification"
      },
      {
        "po": 132,
        "n": "polarity",
        "v": "positive"
      },
      {
        "po": 132,
        "n": "Belief score",
        "v": "0.65"
      },
      {
        "po": 132,
        "n": "Text",
        "v": "Of the five up-regulated genes, P21 and P19 encode for inhibitors for the cyclin D and the CDK4/6 complex; CFOS and CJUN are down stream of ERK and JNK kinases, and KSR1 promotes MEK and RAF phosphorylation."
      },
      {
        "po": 132,
        "n": "indra",
        "v": ""
      },
      {
        "po": 132,
        "n": "supportType",
        "v": "literature"
      }
    ]
  },
  {
    "edgeCitations": [
      {
        "po": [
          2
        ],
        "citations": [
          3
        ]
      },
      {
        "po": [
          6
        ],
        "citations": [
          7
        ]
      },
      {
        "po": [
          9
        ],
        "citations": [
          10
        ]
      },
      {
        "po": [
          12
        ],
        "citations": [
          13
        ]
      },
      {
        "po": [
          15
        ],
        "citations": [
          16
        ]
      },
      {
        "po": [
          18
        ],
        "citations": [
          19
        ]
      },
      {
        "po": [
          21
        ],
        "citations": [
          22
        ]
      },
      {
        "po": [
          24
        ],
        "citations": [
          25
        ]
      },
      {
        "po": [
          27
        ],
        "citations": [
          28
        ]
      },
      {
        "po": [
          30
        ],
        "citations": [
          31
        ]
      },
      {
        "po": [
          33
        ],
        "citations": [
          34
        ]
      },
      {
        "po": [
          37
        ],
        "citations": [
          38
        ]
      },
      {
        "po": [
          40
        ],
        "citations": [
          41
        ]
      },
      {
        "po": [
          43
        ],
        "citations": [
          44
        ]
      },
      {
        "po": [
          46
        ],
        "citations": [
          47
        ]
      },
      {
        "po": [
          51
        ],
        "citations": [
          52
        ]
      },
      {
        "po": [
          55
        ],
        "citations": [
          56
        ]
      },
      {
        "po": [
          60
        ],
        "citations": [
          61
        ]
      },
      {
        "po": [
          64
        ],
        "citations": [
          65
        ]
      },
      {
        "po": [
          67
        ],
        "citations": [
          68
        ]
      },
      {
        "po": [
          72
        ],
        "citations": [
          73
        ]
      },
      {
        "po": [
          75
        ],
        "citations": [
          76,
          77
        ]
      },
      {
        "po": [
          83
        ],
        "citations": [
          84
        ]
      },
      {
        "po": [
          87
        ],
        "citations": [
          88
        ]
      },
      {
        "po": [
          90
        ],
        "citations": [
          91
        ]
      },
      {
        "po": [
          93
        ],
        "citations": [
          94
        ]
      },
      {
        "po": [
          98
        ],
        "citations": [
          99
        ]
      },
      {
        "po": [
          102
        ],
        "citations": [
          103
        ]
      },
      {
        "po": [
          105
        ],
        "citations": [
          106
        ]
      },
      {
        "po": [
          108
        ],
        "citations": [
          109
        ]
      },
      {
        "po": [
          112
        ],
        "citations": [
          113
        ]
      },
      {
        "po": [
          115
        ],
        "citations": [
          116
        ]
      },
      {
        "po": [
          119
        ],
        "citations": [
          120
        ]
      },
      {
        "po": [
          122
        ],
        "citations": [
          123
        ]
      },
      {
        "po": [
          125
        ],
        "citations": [
          126
        ]
      },
      {
        "po": [
          128
        ],
        "citations": [
          129
        ]
      },
      {
        "po": [
          132
        ],
        "citations": [
          133
        ]
      }
    ]
  },
  {
    "edgeSupports": [
      {
        "po": [
          2
        ],
        "supports": [
          4
        ]
      },
      {
        "po": [
          6
        ],
        "supports": [
          8
        ]
      },
      {
        "po": [
          9
        ],
        "supports": [
          11
        ]
      },
      {
        "po": [
          12
        ],
        "supports": [
          14
        ]
      },
      {
        "po": [
          15
        ],
        "supports": [
          17
        ]
      },
      {
        "po": [
          18
        ],
        "supports": [
          20
        ]
      },
      {
        "po": [
          21
        ],
        "supports": [
          23
        ]
      },
      {
        "po": [
          24
        ],
        "supports": [
          26
        ]
      },
      {
        "po": [
          27
        ],
        "supports": [
          29
        ]
      },
      {
        "po": [
          30
        ],
        "supports": [
          32
        ]
      },
      {
        "po": [
          33
        ],
        "supports": [
          35,
          36
        ]
      },
      {
        "po": [
          37
        ],
        "supports": [
          39
        ]
      },
      {
        "po": [
          40
        ],
        "supports": [
          42
        ]
      },
      {
        "po": [
          43
        ],
        "supports": [
          45
        ]
      },
      {
        "po": [
          46
        ],
        "supports": [
          48,
          49
        ]
      },
      {
        "po": [
          51
        ],
        "supports": [
          53
        ]
      },
      {
        "po": [
          55
        ],
        "supports": [
          57,
          58
        ]
      },
      {
        "po": [
          60
        ],
        "supports": [
          62
        ]
      },
      {
        "po": [
          64
        ],
        "supports": [
          66
        ]
      },
      {
        "po": [
          67
        ],
        "supports": [
          69,
          70
        ]
      },
      {
        "po": [
          72
        ],
        "supports": [
          74
        ]
      },
      {
        "po": [
          75
        ],
        "supports": [
          78,
          79,
          80
        ]
      },
      {
        "po": [
          83
        ],
        "supports": [
          85
        ]
      },
      {
        "po": [
          87
        ],
        "supports": [
          89
        ]
      },
      {
        "po": [
          90
        ],
        "supports": [
          92
        ]
      },
      {
        "po": [
          93
        ],
        "supports": [
          95,
          96,
          97
        ]
      },
      {
        "po": [
          98
        ],
        "supports": [
          100
        ]
      },
      {
        "po": [
          102
        ],
        "supports": [
          104
        ]
      },
      {
        "po": [
          105
        ],
        "supports": [
          107
        ]
      },
      {
        "po": [
          108
        ],
        "supports": [
          110,
          111
        ]
      },
      {
        "po": [
          112
        ],
        "supports": [
          114
        ]
      },
      {
        "po": [
          115
        ],
        "supports": [
          117
        ]
      },
      {
        "po": [
          119
        ],
        "supports": [
          121
        ]
      },
      {
        "po": [
          122
        ],
        "supports": [
          124
        ]
      },
      {
        "po": [
          125
        ],
        "supports": [
          127
        ]
      },
      {
        "po": [
          128
        ],
        "supports": [
          130
        ]
      },
      {
        "po": [
          132
        ],
        "supports": [
          134
        ]
      }
    ]
  },
  {
    "networkAttributes": [
      {
        "n": "name",
        "v": "Copy of rasmachine"
      },
      {
        "n": "description",
        "v": "<div>sdfaasd</div>"
      },
      {
        "n": "version",
        "v": "1.1"
      },
      {
        "n": "rights",
        "v": "NDEX LIC (http://dev.ndexbio.org)"
      },
      {
        "n": "rightsHolder",
        "v": "RIGHTSHOLDER"
      },
      {
        "n": "author",
        "v": "AUTHOR"
      },
      {
        "n": "reference",
        "v": "<div>sdfgg</div>"
      }
    ]
  },
  {
    "nodeAttributes": [
      {
        "po": 0,
        "n": "type",
        "v": "protein"
      },
      {
        "po": 0,
        "n": "UniProt",
        "v": "http://identifiers.org/uniprot/P15056"
      },
      {
        "po": 0,
        "n": "HGNC",
        "v": "http://identifiers.org/hgnc/HGNC:1097"
      },
      {
        "po": 1,
        "n": "type",
        "v": "proteinfamily"
      },
      {
        "po": 1,
        "n": "BE",
        "v": "http://sorger.med.harvard.edu/indra/entities/ERK"
      },
      {
        "po": 5,
        "n": "type",
        "v": "proteinfamily"
      },
      {
        "po": 5,
        "n": "BE",
        "v": "http://sorger.med.harvard.edu/indra/entities/MEK"
      },
      {
        "po": 50,
        "n": "type",
        "v": "protein"
      },
      {
        "po": 50,
        "n": "UniProt",
        "v": "http://identifiers.org/uniprot/P01116"
      },
      {
        "po": 50,
        "n": "HGNC",
        "v": "http://identifiers.org/hgnc/HGNC:6407"
      },
      {
        "po": 54,
        "n": "type",
        "v": "protein"
      },
      {
        "po": 54,
        "n": "UniProt",
        "v": "http://identifiers.org/uniprot/P04049"
      },
      {
        "po": 54,
        "n": "HGNC",
        "v": "http://identifiers.org/hgnc/HGNC:9829"
      },
      {
        "po": 59,
        "n": "type",
        "v": "bioprocess"
      },
      {
        "po": 59,
        "n": "GO",
        "v": "http://identifiers.org/go/GO:0090398"
      },
      {
        "po": 59,
        "n": "MESH",
        "v": "http://identifiers.org/mesh/D016922"
      },
      {
        "po": 63,
        "n": "type",
        "v": "protein"
      },
      {
        "po": 63,
        "n": "UniProt",
        "v": "http://identifiers.org/uniprot/P00533"
      },
      {
        "po": 63,
        "n": "HGNC",
        "v": "http://identifiers.org/hgnc/HGNC:3236"
      },
      {
        "po": 71,
        "n": "type",
        "v": "protein"
      },
      {
        "po": 71,
        "n": "UniProt",
        "v": "http://identifiers.org/uniprot/Q01726"
      },
      {
        "po": 71,
        "n": "HGNC",
        "v": "http://identifiers.org/hgnc/HGNC:6929"
      },
      {
        "po": 81,
        "n": "type",
        "v": "chemical"
      },
      {
        "po": 81,
        "n": "ChEBI",
        "v": "http://identifiers.org/chebi/CHEBI:75047"
      },
      {
        "po": 82,
        "n": "type",
        "v": "proteinfamily"
      },
      {
        "po": 82,
        "n": "BE",
        "v": "http://sorger.med.harvard.edu/indra/entities/RAF"
      },
      {
        "po": 86,
        "n": "type",
        "v": "chemical"
      },
      {
        "po": 86,
        "n": "ChEBI",
        "v": "http://identifiers.org/chebi/CHEBI:63637"
      },
      {
        "po": 86,
        "n": "PubChem",
        "v": "http://identifiers.org/pubchem.compound/42611257"
      },
      {
        "po": 101,
        "n": "type",
        "v": "chemical"
      },
      {
        "po": 101,
        "n": "PubChem",
        "v": "http://identifiers.org/pubchem.compound/44462760"
      },
      {
        "po": 118,
        "n": "type",
        "v": "chemical"
      },
      {
        "po": 118,
        "n": "PubChem",
        "v": "http://identifiers.org/pubchem.compound/11707110"
      },
      {
        "po": 131,
        "n": "type",
        "v": "protein"
      },
      {
        "po": 131,
        "n": "UniProt",
        "v": "http://identifiers.org/uniprot/Q8IVT5"
      },
      {
        "po": 131,
        "n": "HGNC",
        "v": "http://identifiers.org/hgnc/HGNC:6465"
      }
    ]
  },
  {
    "status": [
      {
        "error": "",
        "success": true
      }
    ]
  }
]